ARCHIVES

Varmus: Why are scientific societies obstructing public access to research results?

This article is from The Cancer Letter archive.

Vol. 31 No. 20 | May 20, 2005

Download PDF Visit The Full Archive

Related Articles

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

L.I. Center At Stony Brook’s Goal Is Comprehensive Status.

October 27, 2000

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program

June 24, 1977